Literature DB >> 20332115

Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.

Lauréline Roger1, Laurent Jullien, Véronique Gire, Pierre Roux.   

Abstract

Mutations in the p53 tumour suppressor gene are associated clinically with tumour progression and metastasis. Downregulation of the E-cadherin cell-cell adhesion molecule is a key event for epithelial to mesenchymal transition (EMT) in tumour progression. Here, we show that wild-type p53 induced to adopt a mutant conformation, and hot-spot p53 mutants, which are both transcriptionally inactive, downregulate E-cadherin expression in the colon carcinoma cell line HCT116. Downregulation of E-cadherin occurred concomitantly with the upregulation of Slug and Zeb-1, transcriptional factors known to repress E-cadherin gene expression. In addition, knockdown of Slug and Zeb-1 expression diminished p53-mediated E-cadherin repression. Knocking down endogenous mutant p53 in MDA-MB-231 and SW620 cancer cell lines lacking E-cadherin protein restored the expression of E-cadherin. Complete loss of E-cadherin expression in HCT116 cells induced morphological alterations along with upregulation of vimentin, a mesenchymal marker. These changes characteristic of the EMT phenotype were, however, not sufficient to confer invasiveness in a three-dimensional matrix. Downregulation of E-cadherin by mutant p53 was not required to promote the invasive phenotype induced by inactivation of p53. These findings indicate that independent control of E-cadherin expression and cell motility could be essential molecular events in p53 mutant-induced invasive phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332115     DOI: 10.1242/jcs.061002

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  49 in total

1.  Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.

Authors:  Luisa F Escobar-Hoyos; Alex Penson; Ram Kannan; Hana Cho; Chun-Hao Pan; Rohit K Singh; Lisa H Apken; G Aaron Hobbs; Renhe Luo; Nicolas Lecomte; Sruthi Babu; Fong Cheng Pan; Direna Alonso-Curbelo; John P Morris; Gokce Askan; Olivera Grbovic-Huezo; Paul Ogrodowski; Jonathan Bermeo; Joseph Saglimbeni; Cristian D Cruz; Yu-Jui Ho; Sharon A Lawrence; Jerry P Melchor; Grant A Goda; Karen Bai; Alessandro Pastore; Simon J Hogg; Srivatsan Raghavan; Peter Bailey; David K Chang; Andrew Biankin; Kenneth R Shroyer; Brian M Wolpin; Andrew J Aguirre; Andrea Ventura; Barry Taylor; Channing J Der; Daniel Dominguez; Daniel Kümmel; Andrea Oeckinghaus; Scott W Lowe; Robert K Bradley; Omar Abdel-Wahab; Steven D Leach
Journal:  Cancer Cell       Date:  2020-06-18       Impact factor: 31.743

2.  Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.

Authors:  Zeng Li; Nan Li; Minghua Wu; Xiayu Li; Zhaohui Luo; Xiaoyan Wang
Journal:  Mol Cell Biochem       Date:  2013-06-07       Impact factor: 3.396

3.  Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer.

Authors:  Zhi-Hui Yan; Li-Hong Cui; Xiao-Hui Wang; Chao Li; Xing He
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

4.  Clinicopathological features of stomach cancer with invasive micropapillary component.

Authors:  Takeo Fujita; Naoto Gotohda; Yuichiro Kato; Takahiro Kinoshita; Shinichiro Takahashi; Masaru Konishi; Hiroyuki Daiko; Mitsuyo Nishimura; Takeshi Kuwata; Atsushi Ochiai; Taira Kinoshita
Journal:  Gastric Cancer       Date:  2011-10-12       Impact factor: 7.370

5.  Discovery of a p53 variant that controls metastasis.

Authors:  Chiara Gorrini
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-31       Impact factor: 11.205

6.  New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer.

Authors:  Min-Sun Jin; In Ae Park; Ji Young Kim; Yul Ri Chung; Seock-Ah Im; Kyung-Hun Lee; Hyeong-Gon Moon; Wonshik Han; Dong-Young Noh; Han Suk Ryu
Journal:  Tumour Biol       Date:  2016-02-19

7.  In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription.

Authors:  Cinzia Puppin; Nadia Passon; Francesco Frasca; Riccardo Vigneri; Federica Tomay; Stefania Tomaciello; Giuseppe Damante
Journal:  Cell Oncol (Dordr)       Date:  2011-01-27       Impact factor: 6.730

Review 8.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

9.  TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection.

Authors:  Apostolos Klinakis; Theodoros Rampias
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

10.  Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells.

Authors:  Reiko Satow; Tamaki Hirano; Ryosuke Batori; Tomomi Nakamura; Yumi Murayama; Kiyoko Fukami
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.